Our research and cancer institutes are addressing barriers to clinical trials through Tempus AI's TIME program, a national network of more than 250 active trials reducing the time to activation through AI-assisted precision matching. Dr. Lopez-Chavez and our lung cancer research team were able to successfully enroll a patient in a trial not currently offered in our region in just under two weeks, a process which usually takes six months or more! We look forward to establishing a network-wide approach to quickly connect eligible patients to life-saving trials.
Way to go!
This is one of the best and most ethical uses of AI in medicine. It’s great to see it being used at AHN!